Eagle Genomics

📍 Cambridge, United Kingdom🗓 Founded 2008👥 124 employees💰 Last funded Jan 2019
Software Development🌐 eaglegenomics.com
Website LinkedIn
Eagle Genomics applies network science to biology. We are revealing the impact of the microbiome on humans, animals and the environment to secure a sustainable future for our food, water, soil and the health of our planet. Our mission is to deliver insight from the microbiome to profoundly change our understanding of wellness and even our fundamental assumptions about life on earth. Our platform transforms scientists’ journey to insights, unifying constellations of complex, multi-dimensional data (the data fabric) to explore and extract signals and networks of relationship, otherwise not detectable by humans alone. This is the frontier of science today and nowhere are the opportunities and challenges more significant than in the burgeoning field of the microbiome.
6
Total investors
0
Early stage
2
Mid stage
2
Late stage
2008
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
5
Chile
1
Investor activity2013–2019 · investors recorded per year
201322016220192
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Eagle Genomics?
Eagle Genomics has 6 investors on record on gritt.io, 2 mid-stage and 2 late-stage investors.
When did Eagle Genomics last raise funding?
The most recent investment in Eagle Genomics recorded on gritt.io was in January 2019.
When was Eagle Genomics founded?
Eagle Genomics was founded in 2008.
What industry is Eagle Genomics in?
Eagle Genomics operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Eagle Genomics based?
Eagle Genomics is headquartered in Cambridge, United Kingdom.